First Time Loading...

Avacta Group PLC
LSE:AVCT

Watchlist Manager
Avacta Group PLC Logo
Avacta Group PLC
LSE:AVCT
Watchlist
Price: 46.5 GBX -0.53%
Updated: May 3, 2024

Avacta Group PLC
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Avacta Group PLC
Revenue Peer Comparison

Comparables:
CNTA
AUTL
BCYC
IMCR
GNS

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Avacta Group PLC
LSE:AVCT
Revenue
£16m
CAGR 3-Years
71%
CAGR 5-Years
42%
CAGR 10-Years
19%
Centessa Pharmaceuticals PLC
NASDAQ:CNTA
Revenue
$6.9m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Autolus Therapeutics PLC
NASDAQ:AUTL
Revenue
$1.7m
CAGR 3-Years
0%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bicycle Therapeutics PLC
NASDAQ:BCYC
Revenue
$27m
CAGR 3-Years
37%
CAGR 5-Years
30%
CAGR 10-Years
N/A
Immunocore Holdings PLC
NASDAQ:IMCR
Revenue
£249.4m
CAGR 3-Years
102%
CAGR 5-Years
60%
CAGR 10-Years
N/A
Genus PLC
LSE:GNS
Revenue
£673.1m
CAGR 3-Years
6%
CAGR 5-Years
7%
CAGR 10-Years
6%

See Also

What is Avacta Group PLC's Revenue?
Revenue
16m GBP

Based on the financial report for Jun 30, 2023, Avacta Group PLC's Revenue amounts to 16m GBP.

What is Avacta Group PLC's Revenue growth rate?
Revenue CAGR 10Y
19%

Over the last year, the Revenue growth was 161%. The average annual Revenue growth rates for Avacta Group PLC have been 71% over the past three years , 42% over the past five years , and 19% over the past ten years .